Clinical Utility of a Comprehensive, Whole Genome CMA Testing Platform in Pediatrics: A Prospective Randomized Controlled Trial of Simulated Patients in Physician Practices

• John Peabody ,

  Contributed equally to this work with: John Peabody, Michael Paul

  * E-mail: jpeabody@qurehealthcare.com

  Affiliations University of California, San Francisco, CA, United States of America, University of California, Los Angeles, CA, United States of America, QURE Healthcare, San Francisco, CA, United States of America

  ⨯
• Megan Martin,

  Affiliation Lineagen, Salt Lake City, UT, United States of America

  ⨯
• Lisa DeMaria,

  Affiliation QURE Healthcare, San Francisco, CA, United States of America

  ⨯
• Jhiedon Florentino,

  Affiliation QURE Healthcare, San Francisco, CA, United States of America

  ⨯
• David Paculdo,

  Affiliation QURE Healthcare, San Francisco, CA, United States of America

  ⨯
• Michael Paul ,

  Contributed equally to this work with: John Peabody, Michael Paul

  Affiliation Lineagen, Salt Lake City, UT, United States of America

  ⨯
• Rena Vanzo,

  Affiliation Lineagen, Salt Lake City, UT, United States of America

  ⨯
• E. Robert Wassman ,

  ¶‡ These authors also contributed equally to this work.

  Affiliation Lineagen, Salt Lake City, UT, United States of America

  ⨯
• Trever Burgon

  ¶‡ These authors also contributed equally to this work.

  Affiliation QURE Healthcare, San Francisco, CA, United States of America

  ⨯